AXIM® Biotechnologies’ Manufacturing Partner Empowered Diagnostics Files Emergency Use Authorization With FDA for Use of Its Rapid COVID-19 Neutralizing Antibody Test in Whole Blood at Point-of-Care Locations

NEXT STORY
Global Pharmacovigilance Market Size & Share Will Grow to USD 12.38 Billion by the 2026, according to Facts & Factors
PREV STORY
Ventilators Market Worth $7.72 billion by 2027- Exclusive Report by Meticulous Research® Covering Emerging Growth Factors, Latest Trends and Forecasts, and Pre and Post COVID-19 Estimates
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

OPKO Health Reports 2017 Third Quarter Highlights and Financial Results

RAYALDEE total prescriptions increased 66% in Q3 2017 compared with Q2 20174Kscore utilization increased ...

author_avatar
NASDAQ Market News

Tempus to Participate in the NCI-MATCH Clinical Trial

Having met rigorous qualifications, Tempus joins a select group of commercial and academic laboratories ...

author_avatar
NASDAQ Market News

Adaptimmune Provides Update on Study of NY-ESO SPEAR® T-cell Therapy in Synovial Sarcoma at the European Society for Medical Oncology (ESMO) 2016 Congress

PHILADELPHIA and OXFORD, United Kingdom, Oct. 09, 2016 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

author_avatar
NASDAQ Market News